P16INK4a correlates to human papillomavirus presence, response to radiotherapy and clinical outcome in tonsillar carcinoma

Anticancer Research

Volumn 25, Issue 6 C, 2005, Pages 4375-4383

  Dahlstrand, Hanna Mellin ^a   Lindquist, David ^a   Björnestål, Linda ^a   Ohlsson, Ann ^a   Dalianis, Tina ^a   Munck Wikland, Eva ^a   Elmberger, Göran ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

HPV; HPV ISH; L1 capsid; p16; Prognosis; Radiotherapy; Tonsillar carcinoma

Indexed keywords

PROTEIN P16INK4A;

ADULT; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; DNA HYBRIDIZATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; TONSIL CARCINOMA; TUMOR BIOPSY; VIRUS CAPSID; VIRUS DETECTION; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; PROGNOSIS; TONSILLAR NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 28444464387     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Parkin DM, Pisani P and Ferlay J: Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80: 827-841, 1999.
2. Decker J and Goldstein J: Risk factors in head and neck cancer. New Engl J Med 306: 1151-1155, 1982.
3. Licitra L, Bernier J, Grandi C, Merlano M, Bruzzi P and Lefebvre JL: Cancer of the oropharynx. Crit Rev Oncol Hematol 41: 107-122, 2002.
4. Huffman HT, Karnell LH, Funk GF, Robinson RA and Menck HR: The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg 124: 951-962, 1998.
5. Gillison ML and Shah KV: Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr Opin Oncol 13: 183-188, 2001.
6. Syrjänen K, Syrjänen S, Lamberg M, Pyrhonen S and Nuutinen J: Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 12: 418-424,1983.
7. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19, 1999.
8. zur Hausen H: Papillomaviruses in human cancers. Proc Assoc Am Physicians 111: 581-587, 1999.
9. Naghashfar Z, Sawada E, Kutcher MJ, Swancar J, Gupta J, Daniel R, Kashima H, Woodruff JD and Shah K: Identification of genital tract papillomaviruses HPV-6 and HPV-16 in warts of the oral cavity. J Med Virol 17: 313-324, 1985.
10. de Villiers EM: Viruses in cancers of the head and neck. Adv Otorhinolaryngol 46: 116-123, 1991.
11. Snijders PJ, Cromme FV, van den Brule AJ, Schrijnemakers HF, Snow GB, Meijer CJ and Walboomers JM: Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer 51: 845-850,1992.
12. Alani RM and Munger K: Human papillomaviruses and associated malignancies. J Clin Oncol 16: 330-337, 1998.
13. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV and Sidransky D: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92: 709-720, 2000.
14. Mellin H, Friesland S, Lewensohn R, Dalianis T and Munck-Wikland E: Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 89: 300-304, 2000.
15. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Youngman L, Lehtinen M and Dillner J: Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344: 1125-1131,2001.
16. van Houten VM, Snijders PJ, van den Brekel MW, Kummer JA, Meijer CJ, van Leeuwen B, Denkers F, Smeele LE, Snow GB and Brakenhoff RH: Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 93: 232-235, 2001.
17. Gillison ML: Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 31: 744-754, 2004.
18. Syrjanen S: HPV infections and tonsillar carcinoma. J Clin Pathol 57: 449-455, 2004.
19. Dahlstrand HM and Dalianis T: Presence and influence of human papillomaviruses (HPV) in tonsillar cancer. Adv Cancer Res 93: 59-89, 2005.
20. Paz IB, Cook N, Odom-Maryon T, Xie Y and Wilczynski SP: Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 79: 595-604, 1997.
21. Andl T, Kahn T, Pfuhl A, Nicola T, Erber R, Conradt C, Klein W, Helbig M, Dietz A, Weidauer H and Bosch FX: Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 58: 5-13, 1998.
22. Klussmann JP, Weissenborn SJ, Wieland U, Dries V, Kolligs J, Jungehuelsing M, Eckel HE, Dienes HP, Pfister HJ and Fuchs PG: Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 92: 2875-2884, 2001.
23. Dahlgren L, Mellin H, Wangsa D, Heselmeyer-Haddad K, Bjornestal L, Lindholm J, Munck-Wikland E, Auer G, Ried T and Dalianis T: Comparative genomic hybridization analysis of tonsillar cancer reveals a different pattern of genomic imbalances in human papillomavirus-positive and -negative tumors. Int J Cancer 707: 244-249, 2003.
24. Braakhuis BJ, Snijders PJ, Keune WJ, Meijer CJ, Ruijter-Schippers HJ, Leemans CR and Brakenhoff RH: Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 96: 998-1006, 2004.
25. Snijders PJF, Steenbergen RDM, Top B, Scott SD, Meijer CJLM and Walboomers JMM: Analysis of p53 status in tonsillar carcinomas associated with human papillomavirus. J Gen Vir 75: 2769-2775, 1994.
26. Balz V, Scheckenbach K, Gotte K, Bockmuhl U, Petersen I and Bier H: Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens. Cancer Res 63: 1188-1191, 2003.
27. INK4A and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer 107: 394-400, 2003.
28. Klussmann JP, Gultekin E, Weissenborn SJ, Wieland U, Dries V, Dienes HP, Eckel HE, Pfister HJ and Fuchs PG: Expression of p!6 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 762: 747-753, 2003.
29. Boonstra J: Progression through the G1-phase of the on-going cell cycle. J Cell Biochem 90: 244-252, 2003.
30. Serrano M, Hannon GJ and Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707, 1993.
31. Dyson N, Guida P, Munger K and Harlow E: Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol 66: 6893-6902, 1992.
32. Dyson N, Howley PM, Munger K and Harlow E: The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934-937, 1989.
33. zur Hausen H: Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1288: F55-78, 1996.
34. Li Y, Nichols MA, Shay JW and Xiong Y: Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 54: 6078-6082, 1994.
35. INK4/MTS1 tumour suppressor gene product. EMBO J 14: 503-511, 1995.
36. Sano T, Oyama T, Kashiwabara K, Fukuda T and Nakajima T: Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 753: 1741-1748, 1998.
37. Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D and von Knebel Doeberitz M: Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92: 276-284, 2001.
38. Wiest T, Schwarz E, Enders C, Flechtenmacher C and Bosch FX: Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 21: 1510-1517, 2002.
39. Li W, Thompson CH, O'Brien CJ, McNeil EB, Scolyer RA, Cossart YE, Veness MJ, Walker DM, Morgan GJ and Rose BR: Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer 106: 553-558, 2003.
40. Friesland S, Mellin H, Munck-Wikland E, Nilsson A, Lindholm J, Dalianis T and Lewensohn R: Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma - relation to radiotherapy response and survival. Anticancer Res 27: 529-534, 2001.
41. Mellin H, Dahlgren L, Munck-Wikland E, Lindholm J, Rabbani H, Kalantari M and Dalianis T: Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 102: 152-158, 2002.
42. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ and Snijders PJ: The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76: 1057-1062, 1995.
43. Tieben LM, ter Schegget J, Minnaar RP, Bouwes Bavinck JN, Berkhout RJ, Vermeer BJ, Jebbink MF and Smits HL: Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods 42: 265-279, 1993.
44. Hagmar B, Johansson B, Kalantari M, Petersson Z, Skyldberg B and Walaas L: The incidence of HPV in a Swedish series of invasive cervical carcinoma. Med Oncol Tumor Pharmacother 9: 113-117, 1992.
45. Saiki RK, Bugawan TL, Horn GT, Mullis KB and Erlich HA: Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature 324: 163-166, 1986.
46. El-Mofty SK and Lu DW: Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol 27: 1463-1470, 2003.
47. Badal S, Badal V, Calleja-Macias IE, Kalantari M, Chuang LS, Li BF and Bernard HU: The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation. Virology 324: 483-492, 2004.
48. Delvenne P, Fontaine MA, Delvenne C, Nikkels A and Boniver J: Detection of human papillomaviruses in paraffin-embedded biopsies of cervical intraepithelial lesions: analysis by immunohistochemistry, in situ hybridization, and the polymerase chain reaction. Mod Pathol 7: 113-119, 1994.
49. Lie AK, Skjeldestad FE, Hagen B, Johannessen E, Skarsvag S and Haugen OA: Comparison of light microscopy, in situ hybridization and polymerase chain reaction for detection of human papillomavirus in histological tissue of cervical intraepithelial neoplasia. Apmis 105: 115-120, 1997.
50. Lindel K, Beer KT, Laissue J, Greiner RH and Aebersold DM: Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 92: 805-813, 2001.
51. Mellin H: Human Papillomavirus in Tonsillar Cancer. Stockholm, Karolinska University Press, 2002.
52. Friesland S, Fernberg JO, Lundell G, Munck-Wikland E, Strander H and Lewensohn R: Prognostic impact of complete remission after preoperative irradiation of tonsillar carcinoma: a retrospective analysis of the radiumhemmet data, 1980-1995. Int J Radiat Oncol Biol Phys 45: 1259-1266, 1999.